Haemonetics (HAE) Raw Materials (2011)

Haemonetics (HAE) recorded quarterly Raw Materials of $35.3 million in Q4 2011, up 16.35% quarter-over-quarter from $30.4 million in Q3 2011.

Haemonetics (HAE) Raw Materials (2011) Analysis & Trends

Haemonetics' Raw Materials history runs 1 years deep, the most recent figure standing at $35.3 million for Q4 2011.

In Q4 2011, Raw Materials changed N/A year-over-year to $35.3 million; the TTM figure through Oct 2011 stood at $35.3 million (changed N/A YoY), while the FY2011 annual figure was $26.4 million, changed N/A from the prior year.
Raw Materials was $35.3 million for Q4 2011 at Haemonetics, up from $30.4 million in the prior quarter.
In the past five years, Raw Materials ranged from a high of $35.3 million in Q4 2011 to a low of $26.4 million in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Haemonetics	3.50 Bn	3.25 Bn	198.21 Mn

Download Data